Literature DB >> 22339777

New approach to analyze genetic and clinical data in bisphosphonate-induced osteonecrosis of the jaw.

B Balla1, M Vaszilko, J P Kósa, J Podani, I Takács, B Tóbiás, Z Nagy, A Lazáry, P Lakatos.   

Abstract

OBJECTIVES: Osteonecrosis of the jaw (ONJ) is a major complication associated with long-term use of bisphosphonates (BP). We aimed to investigate the effect of CYP2C8 rs1934951 SNP and its relationship to a number of clinical and biochemical factors in 46 Hungarian subjects with bisphosphonate-induced ONJ.
METHODS: Blood samples were collected from each subject and genomic DNA was extracted. SNP analysis of CYP2C8 gene was carried out by predesigned TaqMan primer/probe sets. The genetic data together with clinical and biochemical variables were evaluated by chi-square test, logistic regression, and principal component analysis (PCA).
RESULTS: The risk of mandibular localization of ONJ was 19.2-fold higher in subjects with AG genotype than in normal GG genotype. PCA revealed strong positive correlations between maxillar localization of ONJ and a group of variables including intravenous BP application and serum lipid markers. Mandibular localization of ONJ was correlated positively with serum calcium, 25-hydroxy-vitamin D and PTH levels, oral BP application, and the length of BP therapy. The degree of the disease and the number of recurrences were correlated with the application of hormone-deprivation therapy for breast cancer patients.
CONCLUSION: The statistical approach applying PCA to our data may contribute to the better understanding of factors playing role in the development of bisphosphonate-induced ONJ.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22339777     DOI: 10.1111/j.1601-0825.2012.01912.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  3 in total

1.  Genetic investigation of bisphosphonate-related osteonecrosis of jaw (BRONJ) via whole exome sequencing and bioinformatics.

Authors:  Jee-Hwan Kim; Yong Jae Ko; Ji-young Kim; Yoonsoo Oh; Jihye Hwang; Sangjin Han; Sanguk Kim; Jae-Hoon Lee; Dong-Hoo Han
Journal:  PLoS One       Date:  2015-02-10       Impact factor: 3.240

2.  Identifying genetic variants underlying medication-induced osteonecrosis of the jaw in cancer and osteoporosis: a case control study.

Authors:  Kye Hwa Lee; Su-Hwan Kim; Chang Hyen Kim; Byung Joo Min; Grace Juyun Kim; Younggyun Lim; Hun-Sung Kim; Kang-Min Ahn; Ju Han Kim
Journal:  J Transl Med       Date:  2019-11-20       Impact factor: 5.531

3.  Risk factors and indices of osteomyelitis of the jaw in osteoporosis patients: results from a hospital-based cohort study in Japan.

Authors:  Toru Yamazaki; Masashi Yamori; Shiro Tanaka; Keiichi Yamamoto; Eriko Sumi; Megumi Nishimoto-Sano; Keita Asai; Katsu Takahashi; Takeo Nakayama; Kazuhisa Bessho
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.